Back to Semaglutide research
semaglutide glp 1 agonist other 2025-01-16 ClinicalTrials

Semaglutide's Impact on Adrenal Function and Cortisol Levels Explored in PIANO Study

Glucagon-like Peptide-1 Receptor Agnoists for the Assessment of Adrenal Function

Study Design

Population
Not specified in the provided digest.
Intervention
Semaglutide, dose, route, and duration not specified.
Outcome
Impact on adrenal function and cortisol levels.

Abstract

Glucagon-like Peptide-1 Receptor Agnoists for the Assessment of Adrenal Function - the PIANO Study NCT ID: NCT06608433 Status: COMPLETED Sponsor: University Hospital, Basel, Switzerland Phase: NA Start: 2025-01-16 | Completion: 2025-11-30…

semaglutide glp 1 agonist glp-1r
Source: clinicaltrials:NCT06608433 · Ingested 2026-04-30 · Digest: gemini-2.5-flash